Serum alanine aminotransferase levels, hematocrit rate and body weight correlations before and after hemodialysis session

Clinics

Volumn 64, Issue 10, 2009, Pages 941-945

  Lopes, Edmundo Pessoa ^a   Sette, Luis Henrique B C ^b   Sette, Jorge Bezerra C ^a   Luna, Carlos F ^c   Andrade, Amaro M ^a   Moraes, Maviael ^b   Sette, Paulo C A ^b   Menezes, Roberto ^b   Cavalcanti, Rui L ^b   Conceição, Sergio C ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b Dialysis Unit   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Alanine aminotransferase; Chronic renal failure; Hemodialysis; Hepatitis C

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; FEMALE; HEMATOCRIT; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; TIME; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; FEMALE; HEMATOCRIT; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; ROC CURVE; TIME FACTORS; WEIGHT LOSS; YOUNG ADULT;

EID: 70350555426     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009001000002     Document Type: Article

References (19)

1. Al-Wakeel J, Mailk GH, Al-Mohaya S, Mitwalli A, Baroudi F, El Gamal H, et al. Liver disease in dialysis patients with antibodies to hepatitis C virus. Nephrol Dial Transplant 1996;11:2265-8.
2. Yuki N, Ishida H, Inoue T, Tabat T, Matsushita Y, Sasaki Y, et al. Reappraisal of biochemical hepatitis C activity in hemodialysis patients. J Clin Gastroenterol. 2000;30:187-94.
3. Fabrizi F, Lunghi G, Ganeshan SV, Martin P, Messa P. Hepatitis C virus infection and the dialysis patient. Semin Dial. 2007;20:416-22.
4. Alberti A, Noventa F, Benvegnù L, Boccato S, Gatta A. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Inter Med. 2002;137:961-4.
5. Guh JY, Lai YH, Yang CY, Chen SC, Chuang WL, Hsu TC, Chen HC, Chang WY, Tsai JH. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron. 1995;69:459-65.
6. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Kobayashi S, Irie Y. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology. 1995;109:1295-300.
7. Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, et al. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Am J Kidney Dis. 2001;38:1009-15.
8. Ono K, Ono T, Matsumata T. The pathogenesis of decreased aspartate amino-transferase and alanine aminotransferase activity in the plasma of hemodialysis patients: the role of vitamin B6 deficiency. Clin Nephrol. 1995;43:405-8.
9. Lopes EPA, Gouveia EC, Albuquerque ACC, Sette LHBC, Mello LA, Moreira RC, et al.. Determination of the cutoff value of serum alanine aminotransferase in patients undergoing hemodialysis to identify biochemical activity in patients with hepatitis C viremia. J Clin Virol. 2006;35:298-302.
10. Prati D, Taioli E, Zanalla A, Torre ED, Butell S, Vecchio ED, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Inter Med. 2002;137:1-9.
11. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. Br Med J. 2004;328:983-6.
12. Prati D, Shiffman ML, Diago M, Gane E, Reddy KR, Pockros P, et al. Viral and metabolic factors influencing alanine aminotransferase activity in patients with chronic hepatitis C. J Hepatol. 2006;44:679-85.
13. Cotler SJ, Diaz G, Gundlapalli S, Jakate S, Chawla A, Mital D, et al. Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol. 2002;35:191-5.
14. Rampino T, Arbustini E, Gregorini M, Guallini P, Libetta C, Maggio M, et al. Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor. Kidney Int. 1999;56:2286-91.
15. Badalamenti S, Catania A, Lunghi G, Covini G, Bredi E, Brancaccio D, et al. Changes in viremia and circulating interferon-α during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena? Am J Kidney Dis. 2003;42: 143-50.
16. Azevedo HA, Villela-Nogueira CA, Perez RM, Segadas-Soares JA, Takahashi C, Gaburo, et al. Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function. J Nephrol. 2007;20:609-16.
17. Lemos LB, Perez RM, Lemos MM, Draibe SA, Silva IS, Silva AEB, et al. Hepatitis C among predialysis patients: Prevalence and characteristics in a large cohort of patients. Nephron Clin Pract. 2008;108:c135-40.
18. Hung KY, Lee KC, Yen KD, Tsai TJ, Chen WY. Revised cut off values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant. 1997;12:180-3.
19. Conway B, McLaughlin M, Sharpe P, Harty J. Use of cardiac troponin T in diagnosis and prognosis of cardiac events on chronic haemodialysis. Nephrol Dial Transplant. 2005;20:2759-64.